Skip to content
Search

Latest Stories

COVID-19: Since it's launch on Wednesday, over a million have used NHS 111 coronavirus support

Over one million people have used the dedicated NHS 111 online support for coronavirus since its launch last Wednesday.

According to the latest NHS data, enquiries jumped to a record high of more than 210,000 in a single day.


The new service, which is an update to 111 online, provides people with the right advice and frees up clinical call handlers’ time so they can prioritise phone callers experiencing symptoms.

“NHS staff continue to work around the clock to ensure everyone gets the care, advice and support that they need to deal with coronavirus,” Professor Stephen Powis, NHS national medical director.

The telephone calls to NHS 111 were also up by more than a third last week compared with the same time last year, with an extra 120,000 calls to NHS 111 in the first week of March.

NHS 111 has answered 389,779 calls between February 27 and March 5.

“With more than one million people using the new online service, 111 online is helping people to get specific information and advice at the touch of a button, helping to give people quick advice, increase capacity in the NHS and free up clinicians’ time,” Powis said.

NHS England said it ploughing additional investment into 111 to offer more clinical advice over the phone, with investment set to increase if demand continues to rise.

The government is also working on a COVID-19 Emergency Bill which is expected to have strong safeguards against the disease.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less